Product Images Duloxetine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Duloxetine NDC 55700-628 by Quality Care Products Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

image description - New Doc 2018 05 23

image description - New Doc 2018 05 23

This is a medication package for the drug Duloxetine, 60 mg. The medication is manufactured by Ajanta Pharma Limited in Paithan, India and packaged and distributed by Zm&tq. The package contains 30 capsules and has a white/blue color with a serial number of #30. The GTIN number of the product is 00355700628307 and the NDC number is 55700-0628-30. It is a prescription medication and should be kept out of reach of children and in a controlled temperature environment between 59-86 degrees F. The dosage information is available in the insert or by consulting with a physician. The expiration date is not available.*

figure01 - duloxetine fig01

figure01 - duloxetine fig01

This is a graph showing the proportion of patients with relapse over time (in days) for a treatment with both Placebo and DULOXETINE. The x-axis represents the time in days (from 0 to 250) and the y-axis represents the proportion of patients with relapse (ranging from 0 to 1.0). The graph presents two lines, one for each treatment, where the line for DULOXETINE is at a lower proportion of relapse compared to the line for placebo.*

figure2 - duloxetine fig02

figure2 - duloxetine fig02

The text describes a chart showing the proportion of patients with relapse over time from randomization to relapse (measured in days) for two treatments: a placebo and a drug called DULOXETINE. The chart displays the data using a horizontal axis that represents the time in days and a vertical axis that represents the proportion of patients with relapse. There are five intervals for the proportion of patients with relapse on the vertical axis, ranging from 0 to 10, as well as labels for the two treatments at the bottom. The chart also includes a legend for the treatments, and there are tick marks along the horizontal axis with numbers for the days.*

figure04 - duloxetine fig04

figure04 - duloxetine fig04

figure07 - duloxetine fig07

figure07 - duloxetine fig07

This text appears to be a graph or chart related to the effectiveness of Placebo and Duloxetine in treating pain. The chart shows the percentage of improvement in pain from baseline (BOCF) for Duloxetine at 60/120 mg once daily compared to Placebo. However, a thorough description cannot be provided as the graph/chart is not given in a readable format.*

figure08 - duloxetine fig08

figure08 - duloxetine fig08

figure09 - duloxetine fig09

figure09 - duloxetine fig09

This text appears to be a study result displaying the effectiveness of Duloxetine for pain management in comparison to a placebo treatment. The study consisted of patients taking a daily dose of either 60mg or 120mg of Duloxetine. The graph shows the percentage of improvement in pain from baseline for various dosages.*

duloxetine-structure - duloxetine structure

duloxetine-structure - duloxetine structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.